NBHA responded to the New York Times coverage of the FDA analysis posted by the New England Journal of Medicine on May 9, praising the FDA for continuing to investigate the risks and benefits of long-term bisphosphonate use and encouraging patients to speak with their healthcare providers before discontinuing treatment.
On April 4, the Choosing Wisely initiative, a project of the American Board of Internal Medicine Foundation, released a list of 45 tests or procedures that may be over-utilized, including dual-energy X-ray absorptiometry (DXA) tests in women younger than 65 or men younger than 70 with no risk factors. Several media outlets ran articles on the list of over-utilized tests, with some omitting recommendations regarding utilization of DXA for those with osteoporosis risk factors, thereby failing to portray accurately the recommendations of the Choosing Wisely initiative.
NBHA received more than 190 applications from institutions interested in being considered a site for the prospective 3-year, $29 million CMS-funded initiative that would create a fracture liaison service in the Medicare (and Medicaid age 50 and above) population in up to 80 sites; note that the application deadline has passed and applications are no longer being accepted. NBHA anticipates CMS notification in the next several weeks.
A study published in the New England Journal of Medicine found that some older women with normal bone density may be able to delay follow-up testing, but guidelines for women with or at risk for osteoporosis remain unchanged.